Zobrazeno 1 - 10
of 88
pro vyhledávání: '"Johan, Joly"'
Autor:
Elias De Meyst, Delphine Bertrand, Johan Joly, Michaël Doumen, Anja Marchal, Marc Thelissen, Barbara Neerinckx, René Westhovens, Patrick Verschueren
Publikováno v:
Trials, Vol 25, Iss 1, Pp 1-11 (2024)
Abstract Background The optimal retreatment strategy with rituximab for rheumatoid arthritis (RA) remains a point of discussion. Depending on local guidelines, rituximab can either be administered at fixed intervals or when losing disease control, ba
Externí odkaz:
https://doaj.org/article/742bf8cb669c4897a7aa1570543aec77
Autor:
Piet Geusens, Laurent Meric de Bellefon, Patrick Durez, Ruth Wittoek, Luc De Clerck, Jan Lenaerts, René Westhovens, Kurt de Vlam, Marie Vanthuyne, Yves Piette, Isabelle Peene, Anne Durnez, Bert Vander Cruyssen, Sofia Ajeganova, Pauline Montigny, Sofia Pazmino, Johan Joly, Patrick Verschueren, Rik Joos, Christian von Frenckell, Clio Ribbens, Béatrice André, Michel Malaise, Delphine Bertrand, Luk Corluy, Veerle Taelman, Isabelle Ravelingien, Elke Geens, Johan Vanhoof, Els Van Essche, Barbara Neerinckx, Ioana Gofita, Elisa Docampo, Muriel Stubbe, Mieke Devinck, Bea Maeyaert, YVES BOUTSEN, Mihaela Maruseac, Michael Doumen, Alla Ishchenko, Stephanie Dierckx, Mark Walschot, Marie-Joëlle Kaiser, Philip Remans, Kristof Thevissen, Tom Zwaenepoel, Silvana Di Romana, Marc Vanden Berghe, Joëlle Margaux, Jan Van Offel, Elias De Meyst, Myroslava Kulyk, Nelly Creten, Anna Sileghem, Hubert Berghs, Marleen Coppens, Pascale Volders, Christine Langenaeken, Femke Meynen, Isabelle de Wergifosse, Caroline Verbist, Spyridon Kefalas, Celine Brasseur, Mihaela Sarbu, Charline Rinkin, Sandrine Halleux, Maria Jose Fernandez, Marijke Van Hoydonck, Bernard Bouchez, Catherine Naveau, Emmanuelle Caussin, Jean-Pol Dufour, Véronique Pauly, Kathleen Declerck, Stijn Michiels, Joke Vanderstukken, Evelien Deboeck, Anneleen Moeyersoons, Louis Van Praet, Gilles Blondiaux, Jean-Pierre Brasseur, Laure Tant, Muhammad Soyfoo
Publikováno v:
RMD Open, Vol 10, Iss 3 (2024)
Objectives To investigate if patients with early rheumatoid arthritis responding insufficiently to initial methotrexate (MTX) and bridging glucocorticoids (GCs) could benefit from early but temporary etanercept introduction as a second remission-indu
Externí odkaz:
https://doaj.org/article/cd8d4c0fe99449019149159bcb1998a7
Autor:
Delphine Bertrand, Anke Deprez, Michaël Doumen, Diederik De Cock, Sofia Pazmino, Anja Marchal, Marc Thelissen, Johan Joly, Elias De Meyst, Barbara Neerinckx, René Westhovens, Patrick Verschueren
Publikováno v:
Therapeutic Advances in Musculoskeletal Disease, Vol 16 (2024)
Background: Several retreatment strategies exist for rituximab in rheumatoid arthritis (RA). In some countries, reimbursement criteria require a loss of disease control for rituximab retreatment. Understanding the patients’ and rheumatologists’ p
Externí odkaz:
https://doaj.org/article/9b52c4e05a604ea4a9d5b8b42c1a59d1
Autor:
Michaël Doumen, Elias De Meyst, Cedric Lefevre, Sofia Pazmino, Johan Joly, Delphine Bertrand, Mieke Devinck, René Westhovens, Patrick Verschueren
Publikováno v:
Trials, Vol 24, Iss 1, Pp 1-12 (2023)
Abstract Background Rheumatoid arthritis (RA) considerably impacts patients’ lives. Patients’ confidence in their ability to manage this impact, or self-efficacy, can be supported with self-management interventions. One approach is to use mobile
Externí odkaz:
https://doaj.org/article/ef68c22b7a7849308b4159aa14e1ac72
Autor:
Cyrille H. Haddar, Johan Joly, Anne Carricajo, Paul O. Verhoeven, Florence Grattard, Olivier Mory, Evelyne Begaud, Yves Germani, Aymeric Cantais, Bruno Pozzetto
Publikováno v:
BMC Microbiology, Vol 20, Iss 1, Pp 1-9 (2020)
Abstract Background Despite vaccination programs, Streptococcus pneumoniae remains among the main microorganisms involved in bacterial pneumonia, notably in terms of severity. The prognosis of pneumococcal infections is conditioned in part by the pre
Externí odkaz:
https://doaj.org/article/dc0043442eec446bbdd49090881c2234
Autor:
Michaël Doumen, Diederik De Cock, Sofia Pazmino, Delphine Bertrand, Johan Joly, René Westhovens, Patrick Verschueren
Publikováno v:
Arthritis Care & Research. 75:758-767
OBJECTIVE: This study investigated how psychosocial aspects of disease affect the probability of achieving sustained remission in early rheumatoid arthritis (RA) and explored the directionality of this relationship. METHODS: Data were analyzed from t
Autor:
René Westhovens, An De Groef, Kristien Van der Elst, Philip Moons, Diederik De Cock, Sofia Pazmino, Veerle Stouten, Johan Joly, Patrick Verschueren, Johanna Vriezekolk
Publikováno v:
RMD Open, Vol 6, Iss 1 (2020)
Objectives To identify and characterise a subgroup of patients with early rheumatoid arthritis (RA) reporting not feeling well 1 year after treatment initiation despite achieving optimal disease control according to current treatment standards.Method
Externí odkaz:
https://doaj.org/article/b931d413490742b5984259c51165688e
Autor:
Michaël Doumen, Diederik De Cock, Sofia Pazmino, Delphine Bertrand, Johan Joly, René Westhovens, Patrick Verschueren
Publikováno v:
Arthritis Research & Therapy, Vol 23, Iss 1, Pp 1-1 (2021)
An amendment to this paper has been published and can be accessed via the original article.
Externí odkaz:
https://doaj.org/article/1ecab87a5d7e4cf5a239645210c3ae35
Autor:
Michaël Doumen, Delphine Bertrand, Sofia Pazmino, Diederik De Cock, Veerle Stouten, Johan Joly, Isabelle de Wergifosse, Anneleen Moeyersoons, René Westhovens, Patrick Verschueren
Publikováno v:
Clinical Rheumatology. 42:39-45
Flare Assessment in Rheumatoid Arthritis (FLARE-RA) is a self-administered tool aiming to capture current or recent flares in rheumatoid arthritis (RA). We aimed to externally validate the FLARE-RA instrument and its existing cutoffs for flare detect
Autor:
Rene Westhovens, Patrick Verschueren, Delphine Bertrand, Diederik De Cock, Johan Joly, Sofia Pazmino, Michaël Doumen
Publikováno v:
Annals of the Rheumatic Diseases. 81:1385-1391
ObjectiveFatigue is common in rheumatoid arthritis (RA). We aimed to explore its longitudinal course, predictors and association with disease activity in early RA.MethodsData came from the 2-year treat-to-target trial CareRA (Care in early RA) and it